Research Overview
This blend combines Modified GRF (1-29) / CJC-1295 No DAC with Ipamorelin, pairing a GHRH analog with a selective growth hormone secretagogue. Research has investigated the synergistic amplification of growth hormone release when both GHRH and GHRP pathways are activated simultaneously.
Specifications
Quantity: 2mg CJC-1295 No DAC + 2mg Ipamorelin per vial Form: Lyophilized powder Purity: ≥99% (HPLC verified) Storage: Store the powder refrigerated (2–8°C) or frozen, protected from light and moisture, until the printed expiry. After reconstitution, keep refrigerated (do not freeze); full potency ~1 month, with a noticeable quality drop after ~6 weeks.
For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.